High materiality7/10
Ionis Pharmaceuticals upgraded to Buy from Neutral at UBS
Why it may matterVerify against the original reporting
UBS upgrade suggests meaningful upside.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS upgraded IONS to Buy with a target of $88; current price $42.70.
- UBS Buy target $88
- Price $42.70
Key facts
- 01
Target: $88
- 02
Posted price: $42.7
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.